profile-img
Anna Kaltenboeck

@a_kaltenboeck

Health econ & policy #drugpricing Head of RxReimbursement @ATIAdvisory. Former Senate Finance. Views my own. https://t.co/7XAioYYjoY @annakal.bsky.social

calendar_today25-09-2016 16:29:48

1,2K Tweets

731 Followers

1,6K Following

Anna Kaltenboeck(@a_kaltenboeck) 's Twitter Profile Photo
Anna Kaltenboeck
@a_kaltenboeck

7 months ago

$SRPT has been testing the boundaries of FDA evidence standards for pretty much its entire history. Looks like they have no plans to change strategies for confirmatory trials. It's sad for patients. And not a good look that this CEO drew a $124 million salary in 2022.

account_circle